hsa-mir-647: Hsa-mir-647 is a microRNA that is not associated with any specific diseases [PMC6995532]. In a study comparing bone marrow mesenchymal stem cells (BMSCs) from patients with steroid-induced osteonecrosis of the femoral head (SONFH) and patients with femoral neck fracture (FNF), hsa-mir-647 was found to be upregulated in the SONFH group [PMC5887684]. Another study found that hsa-mir-647 was downregulated in spinal cord samples from patients with amyotrophic lateral sclerosis (ALS) [PMC6834740]. Bioinformatical analysis revealed that hsa-mir-647 has potential binding sites in the circular RNA hsa_circ_0004018 [PMC5601662]. Hsa-mir-647 was also identified as one of the miRNAs in class 3, along with Hsa-miR-567 and Hsa-miR-328 [PMC4035288]. The miRNA target prediction tool miRTarBase identified 58 predicted target genes for hsa-mir-647 [PMC6995532]. In addition, hsa-mir-647 has been associated with transcriptional misregulation in cancer and the Hippo signaling pathway, along with other miRNAs such as hsa-miR-626 and hsa-miR-660-3p [PMC5601662]. In an experimental study, hsa-mir-647 mimics were used to co-transfect 293T cells along with a luciferase reporter vector [PMC5779906]. HsamiR_647 has also been identified as a potential target of circular RNA hsa_circ_0000257 [PMC6771114].